Evan Yoo
Podiatrist · Columbia, MDNPI 1912388661
Payments from drug & device makers
Across 54 payments — averaging $23.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Polymedics Innovations Inc.$142
- Smith+Nephew$139
- Ortho Dermatologics, A Division Of Bausch Health US, LLC$124
- Amgen$122
- Molecular Biologicals, Inc$82
- Paratek Pharmaceuticals, Inc.$75
- plus $589 from 16 others
What the payments were for
- Food & beverage$1,273100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Polymedics Innovations Inc. | 1 | $142 |
| Smith+Nephew | 7 | $139 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 6 | $124 |
| Amgen(2 entities) | 6 | $122 |
| Molecular Biologicals, Inc | 1 | $82 |
| Paratek Pharmaceuticals, Inc. | 4 | $75 |
| GRT US Holding, Inc. | 3 | $58 |
| Averitas Pharma Inc. | 2 | $57 |
| Nevro Corp. | 3 | $53 |
| Sebela Pharmaceuticals Inc. | 3 | $53 |
| AbbVie | 2 | $51 |
| Cashflow Solutions, LLC | 3 | $48 |
| Melinta Therapeutics, LLC | 2 | $46 |
| IBSA Pharma Inc. | 2 | $42 |
| Bioventus LLC | 2 | $39 |
| Tactile Systems Technology Inc | 1 | $29 |
| Zimmer Biomet | 1 | $27 |
| GE HealthCare | 1 | $25 |
| Orthofix Medical, Inc. | 1 | $22 |
| Globus Medical | 1 | $14 |
| Biowound Solutions, Inc. | 1 | $13 |
| Merck | 1 | $11 |
How this compares
$1,273 in reported general payments places this provider in the 60th percentile of 183 podiatrist providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciclopirox | 79 | $5,758 |
| Ketoconazole | 184 | $4,799 |
| Diclofenac Sodium | 14 | $667 |
| Mupirocin | 34 | $340 |
| CiclopiroxCiclopirox Olamine | 11 | $319 |
| Methylprednisolone | 36 | $188 |
| Meloxicam | 15 | $49 |
| Oxycodone Hcl | 11 | $39 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Columbia
- Daniel HalaykoColumbia$3K
- Ogechukwu ImonugoColumbia$2K
- Ira GottliebPasadena$4.6M
- Ijeoma NwujuBethesda$601K
- David Linla Plata$75K
- Teresa HilliardHyattsville$19K
- Andreas KaikisHagerstown$17K
- Tiffany HohBaltimore$17K
- Shashank SrivastavaFrederick$15K
- Hayden HofflerCatonsville$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.